
Zian Tseng, MD
Zian H. Tseng, M.D., M.A.S., a cardiologist and a cardiac electrophysiologist, has special interest in risk stratification of patients prone to sudden death and ventricular arrhythmias. He was born and raised in the Bay Area and is an alumnus of the UCSF School of Medicine, where he also completed a year of graduate studies in Biomedical Sciences and a Masters in Clinical Research. He completed his clinical training in internal medicine, cardiology, and cardiac electrophysiology at UCSF.
CLINICAL INTERESTS:
1) Treatment of complex supraventricular arrhythmias, including catheter ablation of atrial fibrillation and left atrial tachycardias occurring after atrial fibrillation ablation
2) Treatment and catheter ablation of ventricular tachycardia, including epicardial mapping and ablation
3) Treatment, risk stratification, and catheter ablation of arrhythmias in adult patients with congenital heart disease
4) Risk stratification and treatment of patients with genetic arrhythmia syndromes
5) Implantation of intracardiac devices for treatment of heart failure (resynchronization) and risk of sudden cardiac death (defibrillators)
6) Application of new device technologies
RESEARCH ACTIVITIES:
1) Principal Investigator for the POstmortem Systematic InvesTigation of Sudden Cardiac Death (POST SCD) Study, a collaboration with Dr. Ellen Moffatt in the San Francisco Office of the Chief Medical Examiner to more accurately define SCD, arrhythmic death, and its epidemiology, mechanisms, and risk factors, continuously funded by the NIH/NHLBI since 2010
2) Principal Investigator for the San Francisco POstmortem Systematic InvesTigation of Sudden Death Young (POST SDY) Study, to more accurately define sudden death in pediatric populations, funded by the CDC since 2015
3) Genetic epidemiology, novel molecular mechanisms, and risk factors for sudden cardiac arrest
4) Principal Investigator for NIH/NHLBI-funded HIV POST SCD Study: SCD and ventricular arrhythmias in the setting of HIV disease
5) Sudden neurologic death
6) Sudden death risk and public/health policy for use of Tasers (electrical conductive devices) by law enforcement agencies